VENITI is a medical device company developing a suite of innovative technology and solutions that will provide comprehensive treatment across the venous disease continuum. Acquired by Boston Scientific for $160 million in August 2018.

For more information, visit Veniti or follow their updates on:

Veniti to be Bought in $160 Million Deal


Cultivation Capital’s Life Sciences Fund Finds Sweet Spot

Veniti’s CFO Catherine Matthes on Clinical Trial Funding

How St. Louis Startup Pulse Therapeutics Attracted Success


Like it? Share it!